{"title":"Modulation of pro-inflammatory mRNA expression by Sesamum indicum and Coptis teeta","authors":"Lopamudra Sarma , Manoj Sharma , Munmi Majumder , Pallab Kumar Borah , Rupak Mukhopadhyay , Raj Kumar Duary","doi":"10.1016/j.prenap.2025.100289","DOIUrl":null,"url":null,"abstract":"<div><div><em>Sesamum indicum</em> Linn. and <em>Coptis teeta</em> Wall<em>.</em> are known to demonstrate significant anti-inflammatory activity, albeit their effect on the expression of pro-inflammatory mRNA has remained largely unexplored. In this study, both the plant extracts demonstrated high polyphenolic (phenolic, 477.50 ± 1.60 and 290.35 ± 1.18 mg GAE (gallic acid equivalent) 100 g<sup>−1</sup>; flavonoid, 225.50 ± 2.77 and 129.54 ± 3.16 mg GAE 100 g<sup>−1</sup>) and antioxidant (ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical scavenging, 89.52 ± 1.25 and 89.95 ± 3.04 %) activities. In lipopolysaccharide-stimulated macrophages differentiated from the human THP-1 monocytic cell line, <em>Sesamum indicum</em> Linn. significantly downregulated the gene expression of pro-inflammatory cytokines, namely, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and cyclooxygenase-2 (COX-2), whereas <em>Coptis teeta</em> Wall<em>.</em> specifically downregulated the gene expression of IL-6. The primary anti-inflammatory compounds were identified as <em>O</em>-coumaric acid, rhamnetin, cucurbitacin H, and harpagoside. The findings offer a promising platform to inform future applications of traditional medicinal plants in functional food and pharmaceutical ingredients development.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"8 ","pages":"Article 100289"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950199725001491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Sesamum indicum Linn. and Coptis teeta Wall. are known to demonstrate significant anti-inflammatory activity, albeit their effect on the expression of pro-inflammatory mRNA has remained largely unexplored. In this study, both the plant extracts demonstrated high polyphenolic (phenolic, 477.50 ± 1.60 and 290.35 ± 1.18 mg GAE (gallic acid equivalent) 100 g−1; flavonoid, 225.50 ± 2.77 and 129.54 ± 3.16 mg GAE 100 g−1) and antioxidant (ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical scavenging, 89.52 ± 1.25 and 89.95 ± 3.04 %) activities. In lipopolysaccharide-stimulated macrophages differentiated from the human THP-1 monocytic cell line, Sesamum indicum Linn. significantly downregulated the gene expression of pro-inflammatory cytokines, namely, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and cyclooxygenase-2 (COX-2), whereas Coptis teeta Wall. specifically downregulated the gene expression of IL-6. The primary anti-inflammatory compounds were identified as O-coumaric acid, rhamnetin, cucurbitacin H, and harpagoside. The findings offer a promising platform to inform future applications of traditional medicinal plants in functional food and pharmaceutical ingredients development.